Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
Goldhaber
Samuel Z
SZ
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA. sgoldhaber@partners.org
Fanikos
John
J
D000328:Adult; D000337:Aerospace Medicine; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D003645:Death, Sudden / Q000209:etiology / Q000517:prevention & control; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008019:Life Style; D008297:Male; D009765:Obesity / Q000150:complications; D011134:Polysaccharides / Q000008:administration & dosage / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000517:prevention & control*; D012907:Smoking / Q000009:adverse effects; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D000077425:Fondaparinux